M. cymbalaria improves glucose tolerance

16 March 2009

A team of Indian scientists has conducted animal studies showing that the roots of a cucumber-like vegetable could have potential in the  treatment of type 2 diabetes.

Presented at Diabetes UK's Annual Professional Conference in Glasgow,  Scotland, data from the trials indicate that aqueous extract of  Momordica cymbalaria (250g/kg) and (500g/kg) improves glucose tolerance  54.3% and 113.8%. In the trial, the commonly-used diabetes drug  glyburide achieved 224.4% improvement.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight